149 related articles for article (PubMed ID: 2159656)
1. Diminished superoxide production of synovial fluid neutrophils in patients with rheumatoid arthritis following piroxicam treatment.
Biemond P; Han H; Swaak AJ; Koster JF
Scand J Rheumatol; 1990; 19(2):151-6. PubMed ID: 2159656
[TBL] [Abstract][Full Text] [Related]
2. Effect of piroxicam therapy on granulocyte function and granulocyte elastase concentration in peripheral blood and synovial fluid of rheumatoid arthritis patients.
Montecucco C; Mazzone A; Pasotti D; Caporali R; Longhi M; Casilli D; Ricevuti G; Fratino P; Ruffilli MP
Inflammation; 1989 Apr; 13(2):211-20. PubMed ID: 2547713
[TBL] [Abstract][Full Text] [Related]
3. Potential of a 70 kDa IL-10-like factor in synovial fluid from rheumatoid arthritis patients to augment superoxide generation by human neutrophils.
Nakamura T; Yamamoto T
Int J Rheum Dis; 2016 Feb; 19(2):150-8. PubMed ID: 24119062
[TBL] [Abstract][Full Text] [Related]
4. Oxidative response of polymorphonuclear leucocytes to synovial fluids from patients with rheumatoid arthritis.
Dularay B; Badesha JS; Dieppe PA; Elson CJ
Ann Rheum Dis; 1990 Sep; 49(9):661-4. PubMed ID: 2173500
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase A2 modulates respiratory burst developed by neutrophils in patients with rheumatoid arthritis.
Bostan M; Galatiuc C; Hirt M; Constantin MC; Brasoveanu LI; Iordachescu D
J Cell Mol Med; 2003; 7(1):57-66. PubMed ID: 12767262
[TBL] [Abstract][Full Text] [Related]
6. Altered function of synovial fluid granulocytes in patients with acute inflammatory arthritis: evidence for activation of neutrophils and its mediation by a factor present in synovial fluid.
Bender JG; Van Epps DE; Searles R; Williams RC
Inflammation; 1986 Dec; 10(4):443-53. PubMed ID: 3025094
[TBL] [Abstract][Full Text] [Related]
7. Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase.
Biemond P; Swaak AJ; Penders JM; Beindorff CM; Koster JF
Ann Rheum Dis; 1986 Mar; 45(3):249-55. PubMed ID: 3006613
[TBL] [Abstract][Full Text] [Related]
8. [The production of superoxide anion (O2-) by polymorphonuclear cells in patients with rheumatoid arthritis].
Lalumera M; Berti C; Pellegrini R; Morozzi G; Marcolongo R
Boll Soc Ital Biol Sper; 1982 Apr; 58(7):385-91. PubMed ID: 6282291
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil chemiluminescence and superoxide production in patients with rheumatoid arthritis: the effect of zymosan, phorbol myristate acetate and platelet-activating factor.
Chou CT; Shaio MF; Chang FY; Chang ML
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):281-8. PubMed ID: 1667989
[TBL] [Abstract][Full Text] [Related]
10. Alterations in neutrophil superoxide production following piroxicam therapy in patients with rheumatoid arthritis.
Van Epps DE; Greiwe S; Potter J; Goodwin J
Inflammation; 1987 Mar; 11(1):59-72. PubMed ID: 3032795
[TBL] [Abstract][Full Text] [Related]
11. Arachidonic acid metabolism in neutrophil granulocytes obtained from synovial fluid in rheumatoid arthritis.
Langholz E; Nielsen OH; Ahnfelt-Rønne I; Elmgreen J
Scand J Rheumatol; 1990; 19(6):387-91. PubMed ID: 2175453
[TBL] [Abstract][Full Text] [Related]
12. Differential stimulation by oxygen-free-radical-altered immunoglobulin G of the production of superoxide and hydrogen peroxide by human polymorphonuclear leucocytes.
Kleinveld HA; Sluiter W; Boonman AM; Swaak AJ; Hack CE; Koster JF
Clin Sci (Lond); 1991 Apr; 80(4):385-91. PubMed ID: 1851075
[TBL] [Abstract][Full Text] [Related]
13. Superoxide anion production by circulating polymorphonuclear leucocytes in rheumatoid arthritis.
Cencetti A; De Martino M; Graziani E; Maddali Bongi S; Palermo C; Pavari E; Zoppi M
Clin Rheumatol; 1990 Mar; 9(1):51-5. PubMed ID: 2159392
[TBL] [Abstract][Full Text] [Related]
14. Chemotactic activity for polymorphonuclear and mononuclear leukocytes in rheumatoid synovial fluids.
Okamoto T; Ueda K; Kambara T; Kutsuna T
Acta Pathol Jpn; 1986 Aug; 36(8):1109-22. PubMed ID: 3776528
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of oxidative stress by allylpyrocatechol in synovial cellular infiltrate of patients with Rheumatoid Arthritis.
Kundu S; Bala A; Ghosh P; Mukhopadhyay D; Mitra A; Sarkar A; Bauri AK; Ghosh A; Chattopadhyay S; Chatterjee M
Free Radic Res; 2011 May; 45(5):518-26. PubMed ID: 21284489
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: critical involvement of the interaction with synovial fibroblasts.
Kasama T; Shiozawa F; Kobayashi K; Yajima N; Hanyuda M; Takeuchi HT; Mori Y; Negishi M; Ide H; Adachi M
Arthritis Rheum; 2001 Nov; 44(11):2512-24. PubMed ID: 11710707
[TBL] [Abstract][Full Text] [Related]
17. [Synovial tissue levels in comparison with synovial fluid and serum concentrations following a single daily administration of 20 mg piroxicam (Felden)].
Thabe H; Fassbender HG; Laufen H; Gierend M
Z Rheumatol; 1986; 45(5):271-6. PubMed ID: 3811635
[TBL] [Abstract][Full Text] [Related]
18. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.
Trnavská Z; Trnavský K; Zlnay D
Eur J Clin Pharmacol; 1984; 26(4):457-61. PubMed ID: 6734706
[TBL] [Abstract][Full Text] [Related]
19. Production of PAF-acether by synovial fluid neutrophils in rheumatoid arthritis.
Hilliquin P; Dulioust A; Gregoir C; Arnoux A; Menkés CJ
Inflamm Res; 1995 Aug; 44(8):313-6. PubMed ID: 8581516
[TBL] [Abstract][Full Text] [Related]
20. Transsynovial kinetics of piroxicam in patients with rheumatoid arthritis.
Kurowski M; Dunky A
Eur J Clin Pharmacol; 1988; 34(4):401-6. PubMed ID: 3402526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
